143 related articles for article (PubMed ID: 10650880)
1. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment.
Hernandez I; Sokolov BP
J Neurosci Res; 2000 Jan; 59(2):218-25. PubMed ID: 10650880
[TBL] [Abstract][Full Text] [Related]
2. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics.
Sokolov BP
J Neurochem; 1998 Dec; 71(6):2454-64. PubMed ID: 9832144
[TBL] [Abstract][Full Text] [Related]
3. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
Burnet PW; Eastwood SL; Harrison PJ
Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.
Gurevich EV; Joyce JN
Biol Psychiatry; 1997 Oct; 42(7):529-45. PubMed ID: 9376449
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the "C" and "T" alleles of the 5-HT2A receptor gene in the temporal cortex of normal individuals and schizophrenics.
Polesskaya OO; Sokolov BP
J Neurosci Res; 2002 Mar; 67(6):812-22. PubMed ID: 11891796
[TBL] [Abstract][Full Text] [Related]
6. Differences in the cellular distribution of D1 receptor mRNA in the hippocampus of bipolars and schizophrenics.
Pantazopoulos H; Stone D; Walsh J; Benes FM
Synapse; 2004 Dec; 54(3):147-55. PubMed ID: 15452863
[TBL] [Abstract][Full Text] [Related]
7. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia.
Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ
Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947
[TBL] [Abstract][Full Text] [Related]
8. mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.
Dracheva S; McGurk SR; Haroutunian V
J Neurosci Res; 2005 Mar; 79(6):868-78. PubMed ID: 15696539
[TBL] [Abstract][Full Text] [Related]
9. Association between the serotonin 2A receptor gene and tardive dyskinesia in chronic schizophrenia.
Segman RH; Heresco-Levy U; Finkel B; Goltser T; Shalem R; Schlafman M; Dorevitch A; Yakir A; Greenberg D; Lerner A; Lerer B
Mol Psychiatry; 2001 Mar; 6(2):225-9. PubMed ID: 11317227
[TBL] [Abstract][Full Text] [Related]
10. A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls.
Knable MB; Hyde TM; Murray AM; Herman MM; Kleinman JE
Biol Psychiatry; 1996 Dec; 40(12):1191-9. PubMed ID: 8959283
[TBL] [Abstract][Full Text] [Related]
11. Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.
Webster MJ; Knable MB; O'Grady J; Orthmann J; Weickert CS
Mol Psychiatry; 2002; 7(9):985-94, 924. PubMed ID: 12399952
[TBL] [Abstract][Full Text] [Related]
12. Distribution of serotonin 2A and 2C receptor mRNA expression in the cervical ventral horn and phrenic motoneurons following spinal cord hemisection.
Basura GJ; Zhou SY; Walker PD; Goshgarian HG
Exp Neurol; 2001 Jun; 169(2):255-63. PubMed ID: 11358440
[TBL] [Abstract][Full Text] [Related]
13. Cholecystokinin messenger RNA deficit in frontal and temporal cerebral cortex in schizophrenia.
Virgo L; Humphries C; Mortimer A; Barnes T; Hirsch S; de Belleroche J
Biol Psychiatry; 1995 May; 37(10):694-701. PubMed ID: 7640324
[TBL] [Abstract][Full Text] [Related]
14. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
15. 5-HT6 receptor binding sites in schizophrenia and following antipsychotic drug administration: autoradiographic studies with [125I]SB-258585.
East SZ; Burnet PW; Leslie RA; Roberts JC; Harrison PJ
Synapse; 2002 Sep; 45(3):191-9. PubMed ID: 12112397
[TBL] [Abstract][Full Text] [Related]
16. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia.
Weickert CS; Ligons DL; Romanczyk T; Ungaro G; Hyde TM; Herman MM; Weinberger DR; Kleinman JE
Mol Psychiatry; 2005 Jul; 10(7):637-50. PubMed ID: 15940304
[TBL] [Abstract][Full Text] [Related]
17. Alteration in estrogen receptor alpha mRNA levels in frontal cortex and hippocampus of patients with major mental illness.
Perlman WR; Tomaskovic-Crook E; Montague DM; Webster MJ; Rubinow DR; Kleinman JE; Weickert CS
Biol Psychiatry; 2005 Nov; 58(10):812-24. PubMed ID: 16112656
[TBL] [Abstract][Full Text] [Related]
18. Relationship between three serotonin receptor subtypes (HTR3A, HTR2A and HTR4) and treatment-resistant schizophrenia in the Japanese population.
Ji X; Takahashi N; Saito S; Ishihara R; Maeno N; Inada T; Ozaki N
Neurosci Lett; 2008 Apr; 435(2):95-8. PubMed ID: 18359159
[TBL] [Abstract][Full Text] [Related]
19. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia.
Dracheva S; Elhakem SL; McGurk SR; Davis KL; Haroutunian V
J Neurosci Res; 2004 May; 76(4):581-92. PubMed ID: 15114630
[TBL] [Abstract][Full Text] [Related]
20. Neurochemical alterations in schizophrenia affecting the putative receptor targets of atypical antipsychotics. Focus on dopamine (D1, D3, D4) and 5-HT2a receptors.
Harrison PJ
Br J Psychiatry Suppl; 1999; (38):12-22. PubMed ID: 10884896
[No Abstract] [Full Text] [Related]
[Next] [New Search]
